Equity Method Investments	6 Months Ended
Jun. 30, 2025
Investments, Debt and Equity Securities [Abstract]
Equity Method Investments	Note 6. Equity Method Investments Our current equity method investments primarily relate to our ownership interests in Dong Suh Foods Corporation and Dong Suh Oil & Fats Co. Ltd. As of June 30, 2025, we owned 50.0% and 49.0%, respectively, of these companies' outstanding shares. Our ownership interests may change over time due to investee stock-based compensation arrangements, share issuances or other equity-related transactions. Our investments accounted for under the equity method totaled $665 million as of June 30, 2025 and $635 million as of December 31, 2024. We recorded equity earnings of $19 million and received no cash dividends in the three months ended June 30, 2025 and recorded equity earnings of $48 million and received cash dividends of $2 million in the three months ended June 30, 2024. We recorded equity earnings of $35 million and received cash dividends of $44 million in the six months ended June 30, 2025 and recorded equity earnings of $79 million and received cash dividends of $82 million in the six months ended June 30, 2024. The activity during 2024 included our prior investment in JDE Peet’s N.V. (“JDEP”). During the fourth quarter of 2024, we sold our remaining 85.9 million shares in JDEP to JAB Holding Company and fully exited the investment. During the three months ended March 31, 2024, we recorded an impairment charge of €612 million ($665 million) related to our JDEP investment. This charge was included within Loss on equity method investment transactions in the condensed consolidated statements of earnings.

Our current equity method investments primarily relate to our ownership interests in Dong Suh Foods Corporation and Dong Suh Oil & Fats Co. Ltd. As of June 30, 2025, we owned 50.0% and 49.0%, respectively, of these companies' outstanding shares. Our ownership interests may change over time due to investee stock-based compensation arrangements, share issuances or other equity-related transactions.

Our investments accounted for under the equity method totaled $665 million as of June 30, 2025 and $635 million as of December 31, 2024. We recorded equity earnings of $19 million and received no cash dividends in the three months ended June 30, 2025 and recorded equity earnings of $48 million and received cash dividends of $2 million in the three months ended June 30, 2024. We recorded equity earnings of $35 million and received cash dividends of $44 million in the six months ended June 30, 2025 and recorded equity earnings of $79 million and received cash dividends of $82 million in the six months ended June 30, 2024. The activity during 2024 included our prior investment in JDE Peet’s N.V. (“JDEP”). During the fourth quarter of 2024, we sold our remaining 85.9 million shares in JDEP to JAB Holding Company and fully exited the investment.

During the three months ended March 31, 2024, we recorded an impairment charge of €612 million ($665 million) related to our JDEP investment. This charge was included within Loss on equity method investment transactions in the condensed consolidated statements of earnings.